Metro Healthcare Indonesia Tbk PT
IDX:CARE

Watchlist Manager
Metro Healthcare Indonesia Tbk PT Logo
Metro Healthcare Indonesia Tbk PT
IDX:CARE
Watchlist
Price: 156 IDR 4% Market Closed
Market Cap: 5.2T IDR
Have any thoughts about
Metro Healthcare Indonesia Tbk PT?
Write Note

Net Margin
Metro Healthcare Indonesia Tbk PT

-37.1%
Current
-26%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-37.1%
=
Net Income
-116.2B
/
Revenue
312.9B

Net Margin Across Competitors

Country ID
Market Cap 5.2T IDR
Net Margin
-37%
Country US
Market Cap 83.9B USD
Net Margin
9%
Country SA
Market Cap 98B SAR
Net Margin
22%
Country ZA
Market Cap 24.9B Zac
Net Margin
17%
Country ZA
Market Cap 20.7B Zac
Net Margin
5%
Country CN
Market Cap 133.2B CNY
Net Margin
18%
Country MY
Market Cap 63.3B MYR
Net Margin
11%
Country US
Market Cap 13.7B USD
Net Margin
15%
Country US
Market Cap 13.1B USD
Net Margin
7%
Country TH
Market Cap 421.1B THB
Net Margin
15%
Country IN
Market Cap 997.2B INR
Net Margin
5%
No Stocks Found

Metro Healthcare Indonesia Tbk PT
Glance View

Market Cap
5.2T IDR
Industry
Health Care

PT Metro Healthcare Indonesia Tbk engages in the provision of integrated healthcare services. The company is headquartered in Tangerang, Banten and currently employs 713 full-time employees. The company went IPO on 2020-03-13. The firm operates its business in an integrated health service with hospital under Metro Hospital Group. The company is focused on developing technology-based health services and training centers to produce professionals in health services. The firm offers healthcare service with a range of services and facilities including polyclinic, ICU room, class III inpatient room and Super VIP room ready to cater various type of patients. The firm operates RSIA Bunda Sejahtera, RSU Bina Sehat Mandiri, RSU Metro Hospitals Cikarang, RSU Metro Hospitals Cikupa, RSU Kartini, RSIA Mitra Husada, and RSIA Santo Yusuf. Its subsidiaries include PT Metro Global Medika, PT Metro Healthcare Technologies, PT Metro Medika Abadi, PT Mitra Adika Buana, PT Metro Hospitals Indonesia, PT Metro Mitra Sarana, PT Eka Tunggal Jaya, PT Paramudya Dasa Sakti, PT Indah Nusa Indonesia, PT Sejahtera Berkah Berdikari, and PT Berkarya Sejahtera Gemilang.

CARE Intrinsic Value
13.11 IDR
Overvaluation 92%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-37.1%
=
Net Income
-116.2B
/
Revenue
312.9B
What is the Net Margin of Metro Healthcare Indonesia Tbk PT?

Based on Metro Healthcare Indonesia Tbk PT's most recent financial statements, the company has Net Margin of -37.1%.